Clinical Research In India 2019 - ACRI India

1
Clinical trials are conducted on humans to
examine the efficacy and safety of new drugs,
treatments, and medical devices, and having them
approved before launching them in the market.
Thus, it is one of the most crucial steps of the
drug development process. Contract Research
Organizations, or CROs, are responsible for
designing, monitoring, and managing clinical
trials with the market being dominated by
private players and foreign pharmaceutical
companies. There are a number of private
companies and research organizations who have
put in their efforts into the clinical research
market to help India stand up to the mark. Get
enrolled with Avigna Clinical Reseach Institutes
online clinical research training, and earn a
legitimate certification that can help you become
the professional who can put in his efforts for
the betterment of the clinical research
environment, and bring India to the pinnacle of
clinical research success.
The Indian clinical research market is showing a
significant growth, and is likely to become one
of the industries that will contribute to
strengthen the international economy. Regulatory
changes have brought Indian clinical research
back on track with the market expected to grow
at a compound annual growth rate of around 12.
The Central Drugs Standard Control Organization
of India has put in efforts to improve timelines
and submission approval rates, which are other
factors that have contributed to the return of
Indian clinical trials. Earlier, it was
uncertainty, ambiguity, and growing ethical
concerns that led to Indias slowdown in the
field. But, the Union Health Ministry has been
actively working to amend new clinical research
2
rules. Significant strides have been taken to
bring clinical research in India back on track.
This trend has been positively supported by
several regulatory enhancements introduced by the
Indian government, making it an agreeable and
reliable environment once again, to run
efficient clinical trials in India. What has made
India become such a huge clinical research
industry holder is the prevalence of chronic
lifestyle diseases, and the huge market size and
growth of private hospitals, with a good amount
of spending for research and development. Experts
have studied a number of factors like the latest
development, changing market dynamics, structural
market changes, and market manufacturing trends
over the past few years and have come up with a
report to evaluate the future of clinical
research in India. All kinds of forthcoming
challenges and possibilities must be considered
and determined while performing in any industry.
Keeping this in mind, the report that has been
developed has covered all-inclusive evaluation
based on various factors like upcoming business
opportunities, upcoming investment opportunities,
business challenges, regulatory alliance, market
restraining factors, and industry environment. In
addition, the report has also spoken about
lucrative business strategies that have been
implemented by key competitors that might
include partnerships, amalgamations, product
launches, windups, and recent acquisitions. A
detailed explanation of the competitive landscape
has also been provided to help companies stay
ahead of the curve. With positivity being seen in
the Indian clinical research industry over the
past few years, we can only expect to see an
even brighter future for the industry in 2019.